{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:18:41Z","timestamp":1783693121562,"version":"3.55.0"},"reference-count":32,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21OC0068242"],"award-info":[{"award-number":["NNF21OC0068242"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["TAJ (R323\u20102018\u20103674)"],"award-info":[{"award-number":["TAJ (R323\u20102018\u20103674)"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004331","name":"Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Hypertension is a prevalent and significant risk factor for cardiovascular disease (CVD). The immune system and inflammatory response are involved in the pathophysiology of hypertension. We hypothesize that treating hypertension with colchicine on top of standard therapy, will decrease pulse wave velocity (PWV), left ventricular mass, cardiac\/inflammatory biomarkers. COHERENT was an investigator\u2010initiated, single\u2010center, prospective, randomized, double\u2010blind, placebo\u2010controlled study of the effects of colchicine in patients with hypertension. Potential participants were identified through nationwide health registries. Eligible patients were randomized 1:1 to colchicine 0.5\u00a0mg daily or placebo and treated for 6 months. Assessment of vascular function, echocardiography, and measurement of biomarkers were performed at baseline and at 6 months. The primary endpoint of the trial was change from baseline in carotid\u2010femoral PWV at 6 months. Secondary endpoints included blood pressure, echocardiographic measurements, and cardiac\/inflammatory biomarkers. We screened 183 potential participants, of whom 150 were randomized from August 2021 to July 2025. A total of 75 (50%) were assigned to receive colchicine. Participants had a mean age of 64.5 years (SD 8.0) and 53 (35%) were female, 82 (55%) were active or former smokers, mean systolic blood pressure was 140\u00a0mmHg (SD 16.5), mean diastolic pressure was 86\u00a0mmHg (10.5), and median high sensitivity C\u2010reactive protein was 0.97\u00a0mg\/L (IQR: 0.52\u20132.05). COHERENT is the first trial to investigate the effects of colchicine in patients with hypertension without other known CVD. The trial will provide important data on whether anti\u2010inflammatory therapy should be considered for patients with hypertension.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical Trial registration<\/jats:bold>\n                    :\n                  <\/jats:p>\n                  <jats:p>\n                    Clinicaltrials.gov: NCT04916522, registered June 3, 2021,\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT04916522\">https:\/\/clinicaltrials.gov\/study\/NCT04916522<\/jats:ext-link>\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Practical Applications<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>COHERENT has the potential to determine whether colchicine can modulate pathological processes in hypertension, such as increased arterial stiffness and blood pressure. If the trial outcome is positive, it could impact therapy for millions of hypertensive patients. Since the socio\u2010economic costs of therapy and care related to hypertension and heart disease are enormous, the results from the study may also be important at a broader societal level, given that colchicine is relatively inexpensive, already approved for treatment in patients following myocardial infarction, and widely considered safe to use with an acceptable low level of side effects when used in low doses. Furthermore, this study can help elucidate the pathophysiological pathways from early\u2010stage cardiovascular disease \u2010 where only hypertension is present \u2010 and determine whether anti\u2010inflammatory therapy such as colchicine can help prevent deleterious vascular function changes and potentially prevent progression to overt cardiovascular disease.<\/jats:p>","DOI":"10.1111\/jch.70296","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:26:21Z","timestamp":1780025181000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Randomized Trial to Investigate the Effects of Low\u2010Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT)"],"prefix":"10.1111","volume":"28","author":[{"given":"Adam Femerling","family":"Langhoff","sequence":"first","affiliation":[{"name":"Department of Cardiology Copenhagen University Hospital \u2013 Herlev and Gentofte  Copenhagen Denmark"},{"name":"Center For Translational Cardiology and Pragmatic Randomized Trials Department of Biomedical Sciences Faculty of Health and Medical Sciences University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas Dyrby","family":"Johansen","sequence":"additional","affiliation":[{"name":"Department of Cardiology Copenhagen University Hospital \u2013 Herlev and Gentofte  Copenhagen Denmark"},{"name":"Center For Translational Cardiology and Pragmatic Randomized Trials Department of Biomedical Sciences Faculty of Health and Medical Sciences University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Frimodt\u2010M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Nephrology Copenhagen University Hospital\u2010 Herlev and Gentofte  Copenhagen Denmark"},{"name":"Department of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Sajadieh","sequence":"additional","affiliation":[{"name":"Department of Cardiology Copenhagen University Hospital \u2013 Bispebjerg and Frederiksberg  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Ken","family":"Schramm","sequence":"additional","affiliation":[{"name":"Department of Cardiology Copenhagen University Hospital \u2013 Bispebjerg and Frederiksberg  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Jepps","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Biering\u2010S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Department of Cardiology Copenhagen University Hospital \u2013 Herlev and Gentofte  Copenhagen Denmark"},{"name":"Center For Translational Cardiology and Pragmatic Randomized Trials Department of Biomedical Sciences Faculty of Health and Medical Sciences University of Copenhagen  Copenhagen Denmark"},{"name":"Department of Cardiology Copenhagen University Hospital \u2013 Rigshospitalet  Copenhagen Denmark"},{"name":"Steno Diabetes Center Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"e_1_2_14_2_1","unstructured":"https:\/\/wonder.cdc.gov\/mcd.html.High stakes\u2010turning evidence into action Global report on hypertension2025."},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(20)30752\u20102"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198604173141601"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv318"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.12.027"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.886655"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.09.063"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108894"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.12831"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.5.1236"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.10.061"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003787"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc1002.105135"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2021372"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.05.055"},{"key":"e_1_2_14_18_1","unstructured":"ClinicalTrials.gov.COLchicine and Non\u2010enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes (COLCOT\u2010T2D). Identifier: NCT05633810. [Internet]. 2022 [cited 2026 Apr 7].https:\/\/clinicaltrials.gov\/study\/NCT05633810."},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15688"},{"key":"e_1_2_14_20_1","unstructured":"http:\/\/www.consort\u2010statement.org\/.CONSORT Statement."},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32834fa8b0"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000452448"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199001000-00010"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318061"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14215"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf143"},{"issue":"6","key":"e_1_2_14_28_1","first-page":"32","article-title":"Normal Arterial Stiffness in Familial Mediterranean Fever. Evidence for a Possible Cardiovascular Protective Role of Colchicine","volume":"108","author":"Kukuy O.","year":"2017","journal-title":"Clinical and Experimental Rheumatology"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067\u2010019\u201004601\u20106"},{"issue":"10","key":"e_1_2_14_30_1","article-title":"Validation Study of the Population Included in the Danish Schizophrenia Registry","volume":"66","author":"Svensson E.","year":"2019","journal-title":"Danish Medical Journal"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494818773535"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268818001401"},{"key":"e_1_2_14_33_1","unstructured":"Pulse wave velocity illustration.https:\/\/cardiex.com.https:\/\/cardiex.com\/sphygmocor\u2010technology\/."}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.70296","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jch.70296","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.70296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:47:43Z","timestamp":1783691263000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.70296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1111\/jch.70296"],"URL":"https:\/\/doi.org\/10.1111\/jch.70296","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"2026-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70296"}}